Ascendis Pharma AS (NASDAQ: ASND) stock closed at $168.84 on 3/17/25 after a major increase of 10.4%. Moreover, this advance was accompanied by exceptionally high trading volume at 219% of normal. The stock has performed in line with the market over the last nine months and has risen 15.9% during the last week.
Current PriceTarget Research Rating
Ascendis Pharma AS is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment